Evidence map›Paper›PMID 29147057›Full record

ArticleBulletin of the World Health Organization2017

Lessons learnt during 20 years of the Swedish strategic programme against antibiotic resistance.

Sigvard Mölstad, Sonja Löfmark, Karin Carlin, Mats Erntell, Olov Aspevall, Lars Blad, Håkan Hanberger, Katarina Hedin, Jenny Hellman, Christer Norman and 5 more

Abstract read
In one paragraph

Article in Bulletin of the World Health Organization, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Epidemiology of penicillin allergy labels in a general Swedish population.The journal of allergy and clinical immunology. Global · 2026
    Article
  6. Review
  7. Article
  8. Mapping nationally adopted targets for antimicrobial consumption and stewardship indicators in the human health domain, 25 European Union/European Economic Area countries, 2025.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  9. Review
  10. Article
  11. Antimicrobial ResistantInternational journal of environmental research and public health · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sigvard MölstadDepartment of Clinical Sciences, Lund University, Jan Waldenströmsg 35, 20502, Malmö, Sweden.
Sonja LöfmarkDepartment of Monitoring and Evaluation, Public Health Agency of Sweden, Solna, Sweden.
Karin CarlinDepartment of Monitoring and Evaluation, Public Health Agency of Sweden, Solna, Sweden.
Mats ErntellDepartment of Communicable Disease Control, County of Halland, Halmstad, Sweden.
Olov AspevallDepartment of Monitoring and Evaluation, Public Health Agency of Sweden, Solna, Sweden.
Lars BladDepartment of Communicable Disease Control, County of Värmland, Karlstad, Sweden.
Håkan HanbergerDivision of Infectious Disease, Department of Clinical and Experimental Medicine, Faculty of Medicine, Linköping, Sweden.
Katarina HedinDepartment of Clinical Sciences, General Practice/Family Medicine, Lund University, Malmö, Sweden.
Jenny HellmanDepartment of Monitoring and Evaluation, Public Health Agency of Sweden, Solna, Sweden.
Christer NormanDepartment of Monitoring and Evaluation, Public Health Agency of Sweden, Solna, Sweden.
Gunilla SkoogDepartment of Monitoring and Evaluation, Public Health Agency of Sweden, Solna, Sweden.
Cecilia Stålsby-LundborgGlobal Health Systems and Policy: Medicines, Focusing Antibiotics, Department of Public Health, Stockholm, Sweden.
Karin Tegmark WisellDepartment of Microbiology, Public Health Agency of Sweden, Solna, Sweden.
Christina ÅhrénDepartment of Infectious Diseases, Institution of Biomedicine, Sahlgrenska Academy, Gothenburg, Sweden.
Otto CarsDepartment of Monitoring and Evaluation, Public Health Agency of Sweden, Solna, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing use of antibiotics and rising levels of bacterial resistance to antibiotics are a challenge to global health and development. Successful initiatives for containing the problem need to be communicated and disseminated. In Sweden, a rapid spread of resistant pneumococci in the southern part of the country triggered the formation of the Swedish strategic programme against antibiotic resistance, also known as Strama, in 1995. The creation of the programme was an important starting point for long-term coordinated efforts to tackle antibiotic resistance in the country. This paper describes the main strategies of the programme: committed work at the local and national levels; monitoring of antibiotic use for informed decision-making; a national target for antibiotic prescriptions; surveillance of antibiotic resistance for local, national and global action; tracking resistance trends; infection control to limit spread of resistance; and communication to raise awareness for action and behavioural change. A key element for achieving long-term changes has been the bottom-up approach, including working closely with prescribers at the local level. The work described here and the lessons learnt could inform countries implementing their own national action plans against antibiotic resistance.

Indexed as

Drug Resistance, BacterialAnti-Bacterial AgentsBacterial InfectionsCommunicable Disease ControlGovernment ProgramsHumansPopulation SurveillanceStreptococcus pneumoniaeSwedenAnti-Bacterial Agents

Identifiers

PMID29147057
PMCPMC5677604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.